This is the authors' abstract. We don't add key points for this paper.
Introduction: Low lung function is observed in prematurity-associated lung disease (PLD). We determined optimal cut-off values for spirometry measures to identify preterm born children who have reversible airway disease which is most likely to respond to inhaled therapy. Methods: Children, from the Respiratory Health Outcomes in Neonates (RHiNO) study, aged 7-12 years, who were born ≤34 weeks’ gestation underwent spirometry before and after salbutamol. Receiver operator characteristic (ROC) curves were used to determine optimal cut-offs for sensitivity, specificity, positive and negative predictive values for all spirometry measures to identify optimal associations with bronchodilator responsiveness (≥10% predicted %FEV1 absolute change) utilising Youden’s J statistic. Results: Acceptable lung function data were available from 544 preterm-born children. Mean age and gestational age at birth were 9.6 years and 31 weeks, respectively. 51% were male. The area under the ROC curves (AUROC) were 0.758, 0.825, and 0.816 for %FEV1, percent predicted forced expiratory flows between 25 and 75% of forced vital capacity (%FEF25-75%), and FEV1/FVC ratio respectively but was 0.576 for %FVC. The optimal spirometry cut-off values for optimal Youden’s J statistic values were 85% for percent precited FEV1 (sensitivity: 0.789 and specificity: 0.591, Youden’s J: 0.38); 65% for %FEF25-75% (0.773 and 0.727, 0.50); and 0.80 for FEV1/FVC (0.816 and 0.697, 0.51). Conclusions: Since %FEF25-75% is associated with high variability in children, we conclude that 85% %FEV1 and 0.8 FEV1/FVC are optimal measures to identify bronchodilator response in preterm-born children.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lowe et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: